BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
12.51
+0.05 (0.40%)
At close: Dec 16, 2025, 4:00 PM EST
12.76
+0.25 (2.00%)
After-hours: Dec 16, 2025, 5:03 PM EST
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $448.55 million as of December 16, 2025. Its market cap has decreased by -33.45% in one year.
Market Cap
448.55M
Enterprise Value
159.82M
1-Year Change
-33.45%
Ranking
Category
Stock Price
$12.51
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $448.55M, a decrease of -27.07%. That is a compound annual growth rate of -22.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 448.55M | 116.10% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |